Skip to content
Open access

Triglyceride glucose index, metabolic comorbidity, and cardiovascular disease: a national cohort study

Sep 2026 · BMC Cardiovascular Disorders · Vol 26 · 0 citations · 53 references
Medicine

TL;DR

Findings underscore the partial mediating role of metabolic comorbidities in the TyG index-CVD association and suggest future research should explore residual pathways to fully elucidate this association.

Abstract

The triglyceride-glucose (TyG) index, a widely accepted surrogate biomarker of insulin resistance, strongly predicts cardiovascular disease (CVD) risk. However, the mediating role of metabolic comorbidities in explaining the relationship between the TyG index and cardiovascular disease remains underexplored. Leveraging the longitudinal data from the China Health and Retirement Longitudinal Study (CHARLS), this longitudinal study investigates how metabolic comorbidities mediate the association between the TyG index and cardiovascular risk. This analysis included 9,400 participants aged ≥ 45 years from CHARLS without baseline CVD. The TyG index was computed as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. Incident cardiovascular events, which were defined as physician-confirmed heart disease or stroke, were monitored until 2020. Adjusted Cox proportional hazards models estimated hazard ratios (HR). The mediation analysis quantified the percentage of excess risk (PERM) attributable to metabolic comorbidities. The mean age of the participants was 59.0 ± 9.5 years, and 4 862 (51.7%) were females. Among eligible participants, 2,152 developed cardiovascular diseases over a 9-year follow-up, with 1,627 heart disease cases and 765 strokes. Compared with people with a lower TyG index (< 8.59 [median level]) and no comorbidity, those concurrently with a higher TyG and comorbidity had the highest risk of CVD (adjusted HR, 1.66; 95% CI, 1.47–1.88), coronary heart disease (aHR, 1.44; 95% CI, 1.25–1.66) and stroke (aHR, 2.94; 95% CI, 2.31–3.75). Metabolic comorbidities mediated 48.3% of the TyG-associated CVD risk, predominantly through hypertension, renal impairment, inflammation, and obesity. These findings underscore the partial mediating role of metabolic comorbidities in the TyG index-CVD association. Future research should explore residual pathways to fully elucidate this association.

Read PDF

Similar papers

Review Open access Oct 2026

Comparison analysis of the triglyceride-glucose index, triglyceride-glucose and frailty index in cardiovascular disease and mortality association among patients with rheumatoid arthritis

Cardiovascular disease (CVD) is a major cause of excess mortality among patients with rheumatoid arthritis (RA). Conventional risk assessment may not fully capture the metabolic abnormalities and physiological vulnerability associated with RA. We investigated whether the triglyceride-glucose–frailty index (TyG-FI), whi...

Yang-Yu Xu, Hong Zhao, Yu-Xiang Gao et al. · 0 citations
Open access Oct 2026

Triglyceride-glucose index-based measures as predictors of cardiovascular events: cohort study data

Abstract Background Despite notable progress in early detection and treatment over recent decades, cardiovascular disease (CVD) remains the leading cause of mortality in Lithuania. According to data from the Health Information Centre of the Institute of Hygiene, diseases of the circulatory system accounted for more tha...

D. Lukšienė, R. Paukštaitienė, R. Radišauskas et al. · 0 citations
Review Open access Oct 2026

Glycemic biomarkers and cardiovascular disease in diabetes: a comparative analysis of population-based and clinical cohorts

Background Cardiovascular disease (CVD) remains a major complication contributing to morbidity and mortality among individuals with diabetes. Different glycemic biomarkers reflect distinct aspects of glucose metabolism, but their associations with prevalent CVD across different diabetic populations remain incompletely...

Li-Hong Zhang, Meng-Zhen Liu, Yu Zhang et al. · 0 citations
Review Open access Sep 2026

Triglyceride-glucose-sarcopenia index and risk of cardiovascular diseases in multinational prospective cohorts

The TyG-Sarcopenia index was independently associated with cardiovascular and all-cause mortality and may support cardiovascular risk stratification and SHAP analyses confirming the index’s contributory role alongside conventional predictors.

Zhi-Wei Yan, Ze-Qian Mei, Jiang Cheng et al. · 0 citations
Open access Oct 2026

Insulin resistance metric and risk of all-cause mortality: a comparative population-based study in Portugal

METS-IR was significantly associated with all-cause mortality, highlighting its value as a prognostic marker for identifying high-risk individuals within cardiometabolic populations and identifying a threshold METS-IR may serve as a target for preventive interventions reducing the risk of premature death.

M. Ferreira, M. Mendonca, G. Abreu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.